Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HERC5 antibody (AA 153-284) (FITC)

This anti-HERC5 antibody is a Rabbit Polyclonal antibody detecting HERC5 in . Suitable for Human.
Catalog No. ABIN7150948

Quick Overview for HERC5 antibody (AA 153-284) (FITC) (ABIN7150948)

Target

See all HERC5 Antibodies
HERC5 (Hect Domain and RLD 5 (HERC5))

Reactivity

  • 14
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 13
  • 1
Rabbit

Clonality

  • 14
Polyclonal

Conjugate

  • 12
  • 1
  • 1
This HERC5 antibody is conjugated to FITC

Application

Please inquire
  • Binding Specificity

    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 153-284

    Cross-Reactivity

    Human

    Purification

    >95%, Protein G purified

    Immunogen

    Recombinant Human E3 ISG15--protein ligase HERC5 protein (153-284AA)

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    HERC5 (Hect Domain and RLD 5 (HERC5))

    Alternative Name

    HERC5

    Background

    Background: Major E3 ligase for ISG15 conjugation. Acts as a positive regulator of innate antiviral response in cells induced by interferon. Functions as part of the ISGylation machinery that recognizes target proteins in a broad and relatively non-specific manner. Catalyzes ISGylation of IRF3 which results in sustained activation, it attenuates IRF3-PIN1 interaction, which antagonizes IRF3 ubiquitination and degradation, and boosts the antiviral response. Catalyzes ISGylation of influenza A viral NS1 which attenuates virulence, ISGylated NS1 fails to form homodimers and thus to interact with its RNA targets. Catalyzes ISGylation of papillomavirus type 16 L1 protein which results in dominant-negative effect on virus infectivity. Physically associated with polyribosomes, broadly modifies newly synthesized proteins in a cotranslational manner. In an interferon-stimulated cell, newly translated viral proteins are primary targets of ISG15.

    Aliases: CEB1 antibody, CEBP1 antibody, Cyclin E binding protein 1 antibody, Cyclin-E-binding protein 1 antibody, E3 ISG15--protein ligase HERC5 antibody, HECT domain and RCC1 like domain containing protein 5 antibody, HECT domain and RCC1-like domain-containing protein 5 antibody, Hect domain and RLD 5 antibody, HECT E3 ubiquitin ligase antibody, HERC5 antibody, HERC5_HUMAN antibody, Herc6 antibody

    UniProt

    Q9UII4
You are here:
Chat with us!